Summary
PRA provides a comprehensive range of pharmacovigilance solutions for the entire product life cycle. We deliver flexible and customized services with the ultimate goal of minimizing risk and protecting patient safety. We work in a cross-functional fashion with other solution areas, such as Real World Solutions and Therapeutic Expertise, to better assist clients with the effective management of their drug safety information and provide comprehensive pharmacovigilance services across all phases and key therapeutic areas.
Register to download
Pharmacovigilance and Patient Safety
You may also be interested in:
White Paper
Sponsor and CRO Pharmacovigilance Alliances
Outsourcing pharmacovigilance activities is a standard business practice in a continuously expanding market segment. In the past, outsourced safety…
White Paper
Local Representation: What Clinical Trial Sponsors Need to Know
In this white paper, best practices are described as well as required Sponsor/Local Representative agreement areas. It is important that major…
Newsletter
Pharmacovigilance Nugget #2 Generating a DSUR - November 2017
A Development Safety Update Report (DSUR) is a periodic regulatory safety report used for drugs under development and for marketed products that are…